Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

To Paxil, with love

Jennifer L. Barkin, PhD
Meds
May 12, 2018
241 Shares
Share
Tweet
Share

In 1994, Penguin Books published what would become a national bestseller titled, Listening to Prozac written by Dr. Peter Kramer, a Clinical Professor of Psychiatry at Brown University at the time. Throughout the book, he debates the ethics of “cosmetic pharmacology” a term associated with the transformation of personality traits through medication. Kramer describes several patients as becoming “better than well” on Prozac — more socially adept, less inhibited, and more competent in their daily functioning.  He also reflects on what this means for patients and for society — that a medication can be so powerful as to alter personality.

Over the years, antidepressants have been the subject of much criticism.  Are they really effective in treating depression?  Do their side effects detract significantly from potential benefits?  Are we treating the root cause of the illness or merely applying a metaphorical band-aid? (Band-aids are effective in many of life’s situations.)  Are they associated with increased risk of other chronic illnesses?

These risk-benefit discussions are prudent and scientific assertions must be repeatedly challenged and confirmed or negated.  Still, my non-clinical opinion is as follows: Antidepressants are a bounty of science.  Everything in my personal experience has corroborated this opinion. When discussing reports of an association between drugs with the potential for anticholinergic activity (Paxil and Prozac are in this class) and the increased risk of dementia with an colleague, she said something to the effect of, “I’ll take the quality of life I have now (on Prozac) rather than worry about disease that may never develop.”  Translation:  It’s worth it to feel this good.

When in crisis, my drug of choice has been paroxetine, the generic for Paxil and the namesake of this opinion piece. As a mental health researcher, I am familiar with tools that are used to screen for and diagnosis depression.  On my worst day, I would not have “screened-positive” for depression.  My use has been low-dose, infrequent, interrupted, and not precipitated by any formal diagnosis.  With that said, I share these personal observations.

Inflammation of the mind.  In my experience, a subclinical dose of Paxil did not turn back or halt any avalanche of emotional pain or anxiety brought on by life circumstance.  For instance, in the same summer, my in-laws, both hovering at 80 years old, became ill and died.  Watching them decline, and leave behind everything they loved (they were avid collectors), was an unpleasant awakening.  There were several other overlapping stressors swirling around this central event.  My mother referred to it as, “the perfect storm.”  Low-dose Paxil did not magic that stress away.  It wasn’t until things calmed down that I noticed it was working at all.

Efficiency of thought.  A childhood friend with generalized anxiety disorder said this to me about Paxil:  “It’s like having an intern in my head sorting out garbage.”  I remember that statement clearly because it mirrored my own experience.  It perpetuates a distinct efficiency of thought — the ability to quickly dismiss the unimportant and focus on matters of consequence.  It “trimmed the fat” in my decision processing, freeing up energy I might have misplaced under different circumstances.

Comfortable with gray area. Author Malcolm Gladwell refers to the concept of a “reducing valve,” in his bestseller, The Tipping Point.  This theory, which he attributes to psychologist Walter Mischel, describes a characteristic whereby people have difficulty accepting that two seemingly opposing personality traits can exist in the same individual.  I can attest that, on Paxil, I was able to see a grey area, comfortably accept that it exists, that contradictions in human behavior exist, and move on with my day. The repetitive thoughts that would hang me up in the past (“How could this person care about me and still act like this?” Conclusion: “They must not care about me at all.”) were considered and quickly discarded.  Simply put, I became more efficient with my mental and emotional energy.  My brain choked off negativity and unnecessary time drains with noticeably greater ease when on-drug.

I have privately speculated — without consulting the scientific literature, I admit — if short-term antidepressant use could be an effective teaching tool for individuals with less severe impairment.   Kind of like when I’ve asked myself the question: What would I do on Paxil?

Jennifer L. Barkin is a psychiatric epidemiologist.

Image credit: Shutterstock.com

Prev

Health care is not a service commodity

May 12, 2018 Kevin 2
…
Next

Physician burnout shouldn't be linked to resilience

May 12, 2018 Kevin 10
…

Tagged as: Medications, Psychiatry

Post navigation

< Previous Post
Health care is not a service commodity
Next Post >
Physician burnout shouldn't be linked to resilience

Related Posts

  • A love letter to patients

    Marcie Costello
  • All’s fair in love and medical school

    Jennifer Udom
  • A love-hate relationship with the resume-guided voice

    Lauren Joseph
  • Love something other than medicine? It’s OK.

    Mary Barber
  • Physicians choose love, science, and healing

    Kellie Lease Stecher, MD
  • A teacher’s job is to show love first

    Catherine Cheng, MD

More in Meds

  • The real cause of America’s opioid crisis: Doctors are not to blame

    Richard A. Lawhern, PhD
  • Can personalized medicine live up to its hype in health care?

    Ketan Desai, MD, PhD
  • The effects of the nationwide stimulant shortage on a private psychiatry practice

    Christine Tran-Boynes, DO
  • Why North American medical cannabis can’t compete globally

    Michael Sassano
  • How were we duped and what can we do about the opioid overdose crisis?

    Ronald A. Zent, MD
  • Caught in the middle: How health insurance companies influence cancer drug selection

    Paul Pender, MD
  • Most Popular

  • Past Week

    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • Deaths of despair: an urgent call for a collective response to the crisis in U.S. life expectancy

      Mohammed Umer Waris, MD | Policy
    • Breaking the stigma: Addressing the struggles of physicians

      Jean Antonucci, MD | Physician
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
  • Recent Posts

    • Lazarus: the dead man brought back to life

      William Lynes, MD | Conditions
    • Revolutionizing COPD management with virtual care solutions [PODCAST]

      The Podcast by KevinMD | Podcast
    • What I think it means to be a medical student in the wake of AI

      Jackson J. McCue | Tech
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • The psychoanalytic hammer: lessons in listening and patient-centered care

      Greg Smith, MD | Conditions
    • From rural communities to underserved populations: How telemedicine is bridging health care gaps

      Harvey Castro, MD, MBA | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 9 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Sam Neill's Rare Lymphoma
  • Day in the Life of a Doctor: Treating a Patient With Septic Shock
  • Paxlovid May Lower Long COVID Risk, VA Study Suggests
  • Digital Inhalers May Improve Uncontrolled Asthma Management
  • Another Win for Zolbetuximab in Advanced Gastric/GEJ Cancer

Meeting Coverage

  • Switch to IL-23 Blocker Yields Deep Responses in Recalcitrant Plaque Psoriasis
  • Biomarkers of Response With Enfortumab Vedotin in Advanced Urothelial Cancer
  • At-Home Topical Therapy for Molluscum Contagiosum Gets High Marks
  • Outlook for Itchy Prurigo Nodularis Continues to Improve With IL-31 Antagonist
  • AAAAI President Shares Highlights From the 2023 Meeting
  • Most Popular

  • Past Week

    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • Deaths of despair: an urgent call for a collective response to the crisis in U.S. life expectancy

      Mohammed Umer Waris, MD | Policy
    • Breaking the stigma: Addressing the struggles of physicians

      Jean Antonucci, MD | Physician
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
  • Recent Posts

    • Lazarus: the dead man brought back to life

      William Lynes, MD | Conditions
    • Revolutionizing COPD management with virtual care solutions [PODCAST]

      The Podcast by KevinMD | Podcast
    • What I think it means to be a medical student in the wake of AI

      Jackson J. McCue | Tech
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • The psychoanalytic hammer: lessons in listening and patient-centered care

      Greg Smith, MD | Conditions
    • From rural communities to underserved populations: How telemedicine is bridging health care gaps

      Harvey Castro, MD, MBA | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

To Paxil, with love
9 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...